Finn, Olivera J.
University of Pittsburgh School of Medicine,
United States
2025 Rank: 23281
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 452 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23281 | 23740 |
| Total Cites | 509 | 556 |
| H-index | 12 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 151 | 154 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 164 | 168 |
| Number of Single+First+Last Authored Papers | 203 | 203 |
| Total Cites to Single+First+Last Authored Papers | 334 | 367 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 450 | 470 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
8.45%
|
|
Finn, Olivera J.
University of Pittsburgh School of Medicine,
United States
2024 Rank: 20834
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 436 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20834 | 23217 |
| Total Cites | 553 | 586 |
| H-index | 11 | 11 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 140 | 141 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 159 | 160 |
| Number of Single+First+Last Authored Papers | 201 | 201 |
| Total Cites to Single+First+Last Authored Papers | 385 | 404 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 446 | 460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
5.63%
|
|
Finn, Olivera J.
University of Pittsburgh,
United States
2023 Rank: 20111
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 479 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20111 | 21739 |
| Total Cites | 524 | 573 |
| H-index | 12 | 12 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 135 | 141 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 150 | 160 |
| Number of Single+First+Last Authored Papers | 199 | 199 |
| Total Cites to Single+First+Last Authored Papers | 370 | 404 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 464 | 482 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.19 |
| Self-Citation Percentage |
8.55%
|
|
Finn, Olivera J.
University of Pittsburgh School of Medicine,
United States
2022 Rank: 13553
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 382 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13553 | 14888 |
| Total Cites | 651 | 677 |
| H-index | 12 | 13 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 171 | 173 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 194 | 199 |
| Number of Single+First+Last Authored Papers | 196 | 196 |
| Total Cites to Single+First+Last Authored Papers | 482 | 499 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 568 | 579 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.17 |
| Self-Citation Percentage |
3.84%
|
|
Finn, Olivera J.
University of Pittsburgh School of Medicine,
United States
2021 Rank: 14583
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 372 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14583 | 15229 |
| Total Cites | 959 | 1035 |
| H-index | 14 | 15 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 272 | 280 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 301 | 313 |
| Number of Single+First+Last Authored Papers | 194 | 194 |
| Total Cites to Single+First+Last Authored Papers | 715 | 773 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 812 | 833 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.24 |
| Self-Citation Percentage |
7.34%
|
|
Finn, Olivera J.
University of Pittsburgh School of Medicine,
United States
2020 Rank: 15165
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 352 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15165 | 16495 |
| Total Cites | 660 | 709 |
| H-index | 13 | 13 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 25 | 25 |
| Total Cites to Single Authored Papers | 187 | 190 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 204 | 211 |
| Number of Single+First+Last Authored Papers | 188 | 188 |
| Total Cites to Single+First+Last Authored Papers | 484 | 524 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 546 | 563 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
6.91%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.